Instil Bio, Inc. is a clinical-stage biopharmaceutical company based in Dallas, Texas. They specialize in developing cell therapy for the treatment of various cancers, such as melanoma and non-small cell lung cancer. Their TIL product candidates include ITIL-168 and ITIL-306.